Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 8 to 10 amino acid residues in defined sequence
Patent
1992-08-24
1994-10-18
Lee, Lester L.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
8 to 10 amino acid residues in defined sequence
5303879, 53038825, 530382, 43524027, A61K 3102, C07K 706, C07K 1528
Patent
active
053570421
ABSTRACT:
Peptides comprising fibrin-specific epitopic sequences are used to prepare hybridoma cell lines producing antifibrin-specific monoclonal antibodies substantially devoid of fibrinogen-cross-reactivity obtained by somatic cell fusion. The antibodies are useful for the in vivo and in vitro detection of thrombi and fibrin deposits.
REFERENCES:
patent: 4147765 (1979-04-01), Stephan et al.
patent: 4245040 (1981-01-01), Pilgeram
patent: 4455290 (1984-06-01), Olexa et al.
patent: 4722903 (1988-02-01), Kudryk et al.
patent: 4758524 (1988-07-01), Bundesen et al.
patent: 4916070 (1990-04-01), Matsueda et al.
patent: 4927916 (1990-05-01), Matsueda et al.
patent: 5116613 (1992-05-01), Haver et al.
Hui, et al, Sci 222, 1129-32 (Dec. 9, 1983).
Hessel et al. Eur. J. Biochem. 98, 521-34, 1979.
Bode et al., Science 229:765-767 (1985).
Houranieh et al., Fed. Proc., 44:1846, AB8381 (1985).
Kudryk et al., Molecular Immunology 21(1):89-94 (1984).
Kudryk et al., Molecular Immunology 20(11):1191-1200 (1983).
Matsueda et al., Pept. Struct. and Funct. Proc. 8th Amer. Pept. Symp. Hruby (ed.), pp. 873-876 (1983).
Matsueda et al., Haemostasis 14(1):44 (1984).
Matsueda et al., Fed. Proc. 42:1992, A61375 (1983).
Nossel, H. L., Nature 291:165-167 (1981).
Pacella et al., Molecular Immunology 20(5):521-527 (1983).
Rosebrough et al., Radiology 156:515-517 (1985).
Scheefers-Borchel et al., Proc. Natl. Acad. Sci. USA 82:7091-7095 (1985).
Sobel et al., Thromb. Haemostasis 46(1):240 (1981).
Soria et al., Ann. N.Y. Acad. Sci., 408:665-666 (1983).
Thorpe et al., Hybridoma 3(4):381-384 (1984).
Whitaker et al., Pathology 16(3):357-358 (1984).
Haber Edgar
Hui Kwan
Matsueda Gary R.
Lee Lester L.
Marshall S. G.
The General Hospital Corporation
LandOfFree
Synthetic peptides capable of eliciting fibrin-specific monoclon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic peptides capable of eliciting fibrin-specific monoclon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic peptides capable of eliciting fibrin-specific monoclon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2373976